Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
NCT03331991 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2400
Last updated 2024-07-31
Summary
The purpose of the study on the Prevention of Influenza and Other Wintertime Respiratory Viruses among Healthcare Professionals in Israel Effectiveness of Influenza Vaccine in Preventing Influenza Virus Infection, Missed Work, and Patient Exposure: A Prospective Cohort Study of Healthcare Personnel (to be called the Healthcare Personnel or HCP study throughout this Data Security Plan) is to investigate vaccine effectiveness and respiratory illness among healthcare personnel (HCP). This will help to better understand the factors that influence influenza vaccination choice, individual vaccine response, and whether or not the influenza vaccine helps to prevent influenza in HCP.
Conditions
- Respiratory Tract Disease
- Influenza
Interventions
- BIOLOGICAL
-
exposure to influenza vaccine
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
Clalit Research Institute
collaborator OTHER -
Abt Associates
lead INDUSTRY
Principal Investigators
-
Mark Thompson, PhD · Centers for Disease Control and Prevention
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-28
- Primary Completion
- 2019-07-31
- Completion
- 2019-07-31
Countries
- Israel
Study Locations
More Related Trials
-
Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel
NCT04523324 ·Status: COMPLETED ·Phase: PHASE4
-
Sub Populations of Immune Cells in Influenza A and B Patients
NCT03366402 ·Status: UNKNOWN
-
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
NCT01693380 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults
NCT02027233 ·Status: COMPLETED ·Phase: NA
-
Immune Responses in Health Care Personnel
NCT03323112 ·Status: RECRUITING
-
Evaluation of a School-based Influenza Vaccination Program
NCT00961337 ·Status: COMPLETED ·Phase: PHASE4
-
Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners
NCT01207518 ·Status: UNKNOWN ·Phase: NA
-
Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.
NCT01063608 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 ·Status: COMPLETED
-
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)
NCT01138397 ·Status: COMPLETED ·Phase: PHASE3
-
Hutterite Influenza Prevention Study
NCT00877396 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
NCT00333398 ·Status: COMPLETED ·Phase: PHASE3
-
Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting
NCT02478905 ·Status: COMPLETED
-
Promotion of Influenza Vaccination in Healthcare Workers During the Recruitment Visit
NCT02758145 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers
NCT01481467 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Effectiveness of a Flu Vaccination Campaign for Healthcare Workers of a Teaching Hospital: a Pre-post Study
NCT05783713 ·Status: COMPLETED
-
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
NCT00711295 ·Status: COMPLETED ·Phase: PHASE3
-
Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration
NCT03372967 ·Status: COMPLETED
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)
NCT01551810 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays Units
NCT02198638 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3
-
Real-time Influenza Vaccine Surveillance
NCT01233388 ·Status: COMPLETED
-
Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza
NCT00833885 ·Status: COMPLETED ·Phase: NA
-
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
NCT04794829 ·Status: RECRUITING
-
Protection From Influenza: Determining the Impact of Prior Infection
NCT03004040 ·Status: UNKNOWN